G72.0
Drug-induced myopathy
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
Drug-induced myopathy is a condition characterized by muscle weakness caused by certain medications. It can affect various muscle groups and may develop gradually with ongoing medication use. Recognizing the signs early is important for managing the condition effectively, though medical consultation is essential for an accurate diagnosis and personalized treatment.
Causes & Symptoms
Clinical Causes: Use of statins (cholesterol-lowering drugs) Certain antibiotics, such as fluoroquinolones Immunosuppressants, like corticosteroids Anti-seizure medications Some antiviral drugs Other medications known to impact muscle health
Key Symptoms: Muscle weakness, especially in the hips, shoulders, or thighs Muscle pain or soreness Fatigue during physical activity Difficulty climbing stairs or rising from a seated position Muscle cramps or stiffness Unexplained muscle tenderness or swelling
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a thorough review of medical history and medication use, physical examinations to assess muscle strength, and laboratory tests such as blood tests measuring muscle enzymes like creatine kinase (CK). Additional assessments may include electromyography (EMG) or muscle biopsy if necessary. The goal is to rule out other causes of muscle weakness and confirm a link to medication usage.
Treatment Protocols: Management often includes discontinuing or adjusting the offending medication under medical supervision. Supportive therapies like physical therapy may be recommended to improve muscle strength and function. In some cases, alternative medications can be prescribed. Monitoring and follow-up are important to ensure the recovery of muscle health and prevent recurrence.
Clinical Advice & FAQs
Billing Guidance
Is G72.0 a billable ICD-10 code?
Yes, G72.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G72.0?
Clinical documentation must specify the nature of Drug-induced myopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference